68 reports

MORE THAN ##, ## NATURALLY OCCURRING PEPTIDES HAVE BEEN IDENTIFIED, AND THESE OFTEN HAVE CRUCIAL ROLES IN HUMAN PHYSIOLOGY, INCLUDING ACTIONS AS HORMONES, GROWTH FACTORS, NEUROTRANSMITTERS, ANTI-INFECTIVES OR ION CHANNEL LIGANDS.

  • Cell Therapy
  • Abzena plc
  • Biologics, Inc.
  • Horizon Discovery
  • Merck & Co., Inc.

ACTIVE WOUND REPAIR MODULATORS INCLUDE GROWTH FACTORS, GENE THERAPY AGENTS, STEM CELLS, ANTIBIOTICS/ ANTI-INFECTIVES, HORMONES, MATRIX METALLOPROTEINASE ENZYME INHIBITORS, AND NEUROPEPTIDES.

  • Cell Therapy
  • United States
  • ConvaTec Inc.
  • Covidien plc
  • Smith & Nephew Plc

THE E## GENE CONVERTS THE VIRUS INFECTED CELLS INTO CANCER CELLS.

  • Cell Therapy
  • North America
  • United States
  • Catalent Pharma Solutions, Inc.
  • WuXi AppTec Co.
  • DIABETIC FOOT ULCERS - PIPELINE BY GENENTECH INC, H2 2018
  • DIABETIC FOOT ULCERS - PIPELINE BY HUMAN STEM CELLS INSTITUTE, H2 2018

The company develops anti-infective products such as anti-bacterial compounds, gene-silencing antivirals, locally delivered and orally available nanoRNA therapeutics.

  • Cell Therapy
  • Chronic Disease
  • Type 2 Diabetes
  • Wound Care
  • ViroMed Co., Ltd.
  • DIABETIC FOOT ULCERS - PIPELINE BY HUMAN STEM CELLS INSTITUTE, H1 2018

Mul-## elicits anti-infective activity by an undisclosed mechanism of action.

  • Cell Therapy
  • Pharmaceutical
  • Type 2 Diabetes
  • Wound Care
  • ProMetic Life Sciences Inc.

The company uses alphamer technology to develop anti-infective therapeutics.

  • Cell Therapy
  • United Kingdom
  • United States
  • Company
  • Horizon Discovery
  • PIPELINE BY ASTERIAS BIOTHERAPEUTICS INC, H2 2018

THE COMPANY FOCUSES ON IMMUNO-ONCOLOGY TO TACKLE DRUG RESISTANCE IN TARGETED CANCER THERAPIES AND ANTI-INFECTIVES.

  • Cancer
  • Cell Therapy
  • Lung Cancer
  • Therapy
  • Geron Corporation

The firm' s portfolio consists of several active investments working in the fields of cancer, kidney disease, liver disease, dyslipidemia, inflammatory bowel disease, anti-infectives, central nervous system, pain management and the microbiome.

  • Cell Therapy
  • Pharmaceutical
  • South Korea
  • M&A
  • Green Cross

It offers products for the treatment of anti-infective, autoimmune, cardiovascular, ophthalmic and other non-oncology indications.

  • Cell Therapy
  • Therapy
  • United States
  • Product Initiative
  • Syros Pharmaceuticals, Inc.

The firm' s portfolio consists of several active investments working in the fields of cancer, kidney disease, liver disease, dyslipidemia, inflammatory bowel disease, anti-infectives, central nervous system, pain management and the microbiome.

  • Cell Therapy
  • Pharmaceutical
  • South Korea
  • M&A
  • Green Cross

IMMUNOGLOBULINS ELICIT ANTI-INFECTIVE ACTIVITY.

  • Cell Therapy
  • Medical Biotechnology
  • United States
  • World
  • Chimerix, Inc.

INFECTED SP-B-C MICE DEMONSTRATED INCREASED MORTALITY, LUNG INJURY, APOPTOSIS, AND NF-ΚB EXPRESSION COMPARED WITH INFECTED SP-B-T MICE.

  • Cell Therapy
  • United States
  • Company
  • Product Initiative
  • Can-Fite BioPharma Ltd.

The company' s pipeline products include inhibitors for oncology and anti-infectives for treatment of diseases that include influenza and hepatitis B.

  • Cell Therapy
  • United States
  • Company
  • Product Initiative
  • ProMetic Life Sciences Inc.

In Pharmaceuticals: Baxter showcased its growing generic injectables portfolio across key therapeutic areas including anesthesia, anti-infectives, cardiovascular, oncology and specialty care.

  • Cell Therapy
  • United States
  • Company
  • Company Financials
  • Market Size

It is a next generation anti-infective.

  • Cell Therapy
  • Wound Care
  • United States
  • Company
  • Product Initiative

At Merck, we have never wavered in our commitment to invest in developing anti-infective therapies that prevent and treat serious infectious diseases, " said Dr.

  • Cell Therapy
  • Medical Biotechnology
  • United States
  • World
  • Chimerix, Inc.

It offers products in the areas of eye care, medical aesthetics, dermatology, central nervous system, gastroenterology, women' s health, urology and anti-infective therapeutic categories.

  • Cell Therapy
  • Gene Therapy
  • Pharmaceutical
  • Therapy
  • Amarantus BioScience Holdings, Inc.

The company also develops an anti-HIV vaccine.

  • Cell Therapy
  • Pharmaceutical
  • United States
  • World
  • Product Initiative

EBNA## PROVIDES CELL SURVIVAL FUNCTION IN LATENTLY INFECTED CELLS.

  • Cell Therapy
  • Immunotherapy
  • Monoclonal Antibody
  • Therapy
  • Bristol-Myers Squibb Company

ANTI- C##A TREATMENT IN H##N##-INFECTED MONKEYS SUBSTANTIALLY ATTENUATED ACUTE LUNG INJURY.

  • Blood Disease
  • Cell Therapy
  • Pharmaceutical
  • Therapy
  • Bristol-Myers Squibb Company

It provides pharmaceutical products for use in the areas of gastrointestinal therapy, respiratory therapy, nutraceuticals, anti infective, anticoagulants, and analgesics and antipyretic conditions.

  • Cell Therapy
  • Hepatitis
  • Infectious Disease
  • Vaccine
  • Arbutus Biopharma Corporation

EBNA## PROVIDES CELL SURVIVAL FUNCTION IN LATENTLY INFECTED CELLS.

  • Cancer
  • Cell Therapy
  • Therapy
  • United States
  • Product Initiative

The company offers finished products such as analgestics and opiod analgesics; sedatives, opioid cough suppressant and antitussive; anti microbials, anti infectives, antisepsis, cell metabolism, and others.

  • Cell Therapy
  • Gene Therapy
  • Regenerative Medicine
  • Therapy
  • AnGes MG, Inc.

The company' s pipeline products include inhibitors for oncology and anti-infectives for treatment of diseases that include influenza and hepatitis B.

  • Autoimmune Disease
  • Cell Therapy
  • Australia
  • United States
  • Product Initiative

The company offers finished products such as analgestics and opiod analgesics; sedatives, opioid cough suppressant and antitussive; anti microbials, anti infectives, antisepsis, cell metabolism, and others.

  • Cell Therapy
  • Heart Attack
  • United States
  • Company
  • Product Initiative

It is a next generation anti-infective.

  • Cell Therapy
  • Healthcare
  • Type 2 Diabetes
  • United States
  • Product Initiative

ANTI- C##A TREATMENT IN H##N##-INFECTED MONKEYS SUBSTANTIALLY ATTENUATED ACUTE LUNG INJURY.

  • Blood Disease
  • Cell Therapy
  • Pharmaceutical
  • Therapy
  • Bristol-Myers Squibb Company

This invention relates to compositions that contain multiple modulating agents, e. g., multiple modulating agents that target CD## on T cells and neutralize one or more biological activities of interleukin-## (IL-##), such as CD## modulators including anti-CD## antibodies and

  • Cell Therapy
  • United States
  • Company
  • Product Initiative
  • Anavex Life Sciences Corp.

## ## Germany ## ## ## ## ## ## ## ## Japan ## ## ## ## ## ## ## ## United Kingdom ## ## ## ## ## ## ## ## Canada ## ## ## ## ## ## ## ## France ## ## ## ## ## ## ## ## Italy Source: GlobalData' s Pharma Intelligence Center Clinical

  • Cell Therapy
  • Clinical Trial
  • Drug Development
  • Pharmaceutical
  • World

THE COMPANY FOCUSES ON IMMUNO-ONCOLOGY TO TACKLE DRUG RESISTANCE IN TARGETED CANCER THERAPIES AND ANTI-INFECTIVES.

  • Cancer
  • Cell Therapy
  • United States
  • World
  • Product Initiative